ICU Medical price target raised to $178 from $172 at Piper Sandler

Piper Sandler raised the firm’s price target on ICU Medical (ICUI) to $178 from $172 and keeps an Overweight rating on the shares following quarterly results. Guidance for 2026 bracketed Street like the firm thought and should have consensus EBITDA and EPS rising slightly as models are updated, and it’s increasingly evident that business functions/operations are simply running better with each passing quarter.